CMCR

San Diego Scientist Clears Haze On Medical Marijuana

KPBS, March 3, 2015

When voters passed Proposition 215 in 1996, California became the first state to legalize medical pot. There was only one problem. Scientists still hadn't firmly established marijuana's effectiveness as medicine.

Some state legislators wanted to change that. They approached UC San Diego psychiatrist Igor Grant. "My recommendation was, look, establish a center to study this," said Grant, who'd previously looked into whether moderate marijuana use causes long-term brain damage (conclusion: it doesn't).

Click here to read the rest of the story and watch the program.


 

American Association for the Advancement of Science

Igor Grant, MD, participated in a symposium on medicinal cannabis at the 2015 meeting of the American Association for Advancement of Science in San Jose California on 2/14/15.

Click here for audio from the interview.


 

Welcome to the Center for Medicinal Cannabis Research


Welcome to the University of California's Center for Medicinal Cannabis Research (CMCR). The purpose of the Center is to coordinate rigorous scientific studies to assess the safety and efficacy of cannabis and cannabis compounds for treating medical conditions. The funding of the CMCR is the result of SB 847 (Vasconcellos), passed by the State Legislature and signed into law by Governor Gray Davis. The legislation calls for a three year program overseeing objective, high quality medical research that will "enhance understanding of the efficacy and adverse effects of marijuana as a pharmacological agent," stressing that the project "should not be construed as encouraging or sanctioning the social or recreational use of marijuana" (SB 847).

 

news

 

American Academy of Pediatrics, Policy Statement

Updated policy statement includes option for “compassionate use” of marijuana for children with debilitating or life-limiting diseases

In an updated policy statement and technical report, the American Academy of Pediatrics (AAP) reaffirms its opposition to legalizing marijuana, citing the potential harms to children and adolescents.

The AAP policy statement, “The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update” and an accompanying technical report will be published in the March 2015 Pediatrics (published online Jan. 26). In the policy, the Academy reaffirms its position against the legalization of marijuana, states its opposition to “medical marijuana” outside the FDA regulatory process, and presents recommendations to protect children in states that have legalized marijuana for medical or recreational purposes.

The Academy also recommends that marijuana be decriminalized, so that penalties for marijuana-related offenses are reduced to lesser criminal charges or civil penalties. Efforts to decriminalize marijuana should take place in conjunction with efforts to prevent marijuana use and promote early treatment of adolescents with marijuana use problems.

Read the full press release here.


 
Banner
Banner
Banner

Copyright ©2010 CENTER FOR MEDICINAL CANNABIS RESEARCH | University of California, San Diego
cmcr@ucsd.edu | contact the webmaster | HNRP | HNRC | CNTN | CHARTER